High Tumour PD-L1 Is Associated With Poor Outcomes in EGFR-Mutant Lung Cancer Treated With First Generation EGFR TKIs

被引：0

作者：

Liu, J. ^{[1
]}

Itchins, M. ^{[2
]}

Nagrial, A. ^{[3
]}

Cooper, W. ^{[4
]}

De Silva, M. ^{[2
]}

Barnet, M. ^{[5
]}

Varikatt, W. ^{[6
]}

Sivasubramaniam, V. ^{[7
]}

Davis, A. ^{[8
]}

Gill, A. ^{[2
]}

Blinman, P. ^{[9
]}

Lee, K. ^{[9
]}

Hui, R. ^{[1
]}

Gao, B. ^{[1
]}

Pavlakis, N. ^{[2
]}

Clarke, S. ^{[10
]}

Lee, J. ^{[8
]}

Boyer, M. ^{[8
]}

Kao, S. ^{[8
]}

机构：

[1] Crown Princess Mary Canc Ctr, Dept Med Oncol, Westmead, NSW, Australia

[2] Royal North Shore Hosp, Kolling Inst Med Res, Canc Diag & Pathol Grp, St Leonards, NSW, Australia

[3] Blacktown Hosp, Blacktown, NSW, Australia

[4] Royal Prince Alfred Hosp, Tissue Pathol & Diagnost Oncol, Nsw Hlth Pathol, Nsw Pathol, Camperdown, NSW, Australia

[5] Kinghorn Canc Ctr, Med Oncol, Darlinghurst, NSW, Australia

[6] Westmead Hosp, Tissue Pathol & Diagnost Oncol, Inst Clin Pathol & Med Res, Westmead, NSW, Australia

[7] St Vincents Hosp, Sydpath, Darlinghurst, NSW, Australia

[8] Chris OBrien Lifehouse, Dept Med Oncol, Camperdown, NSW, Australia

[9] Concord Repatriat Gen Hosp, Concord, ACT, Australia

[10] Univ Sydney, Sydney, NSW, Australia

来源：

关键词：

EGFR; PD-L1; primary resistance;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P76.08

引用

页码：S588 / S589

页数：2